Search

everythinglearnresearchcommunity

for

Search:↓

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Bald men may have a lower risk of testicular cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

No link found between hair loss severity and PSA levels in men.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

A new method accurately measures nine specific hormones in human blood.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.